Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Kohl's
KSS
$2.19B
| $38.5M | ﹤0.01% |
1,826,101
+91,608
| +5% | +$1.87M |
|
1602
AstraZeneca
AZN
$250B
| $38.4M | ﹤0.01% |
246,724
+635
| +0.3% | +$103K |
|
1603
Winnebago Industries
WGO
$909M
| $38.4M | ﹤0.01% |
661,250
-7,079
| -1% | -$405K |
|
|
AGR
1604
DELISTED
Avangrid, Inc.
AGR
| $38.4M | ﹤0.01% |
1,072,808
+16,960
| +2% | +$605K |
|
1605
Aspen Aerogels
ASPN
$518M
| $38.4M | ﹤0.01% |
1,385,968
+75,024
| +6% | +$1.88M |
|
1606
CareDx
CDNA
$2.42B
| $38.3M | ﹤0.01% |
1,227,724
+32,141
| +3% | +$800K |
|
1607
FB Financial Corp
FBK
$3.04B
| $38.3M | ﹤0.01% |
815,361
+7,021
| +0.9% | +$315K |
|
1608
Syndax Pharmaceuticals
SNDX
$1.82B
| $38.1M | ﹤0.01% |
1,977,082
+66,459
| +3% | +$1.37M |
|
|
VRNT
1609
DELISTED
Verint Systems
VRNT
| $38M | ﹤0.01% |
1,500,087
+4,034
| +0.3% | +$124K |
|
1610
Peloton Interactive
PTON
$2.49B
| $37.9M | ﹤0.01% |
8,099,427
+13,669
| +0.2% | +$53.7K |
|
|
RDFN
1611
DELISTED
Redfin
RDFN
| $37.9M | ﹤0.01% |
3,022,948
+66,018
| +2% | +$607K |
|
1612
Ardelyx
ARDX
$997M
| $37.8M | ﹤0.01% |
5,487,742
+17,296
| +0.3% | +$102K |
|
|
JBGS
1613
JBG SMITH
JBGS
$708M
| $37.8M | ﹤0.01% |
2,161,842
-29,378
| -1% | -$498K |
|
1614
Empire State Realty Trust
ESRT
$836M
| $37.8M | ﹤0.01% |
3,406,925
+38,529
| +1% | +$402K |
|
1615
Stepan Co
SCL
$1.48B
| $37.6M | ﹤0.01% |
486,976
+4,777
| +1% | +$379K |
|
1616
NovoCure
NVCR
$1.91B
| $37.6M | ﹤0.01% |
2,405,257
+29,871
| +1% | +$542K |
|
1617
United Parks & Resorts
PRKS
$2.12B
| $37.5M | ﹤0.01% |
740,430
-50,141
| -6% | -$2.59M |
|
1618
Arvinas
ARVN
$572M
| $37.4M | ﹤0.01% |
1,519,334
-22,403
| -1% | -$585K |
|
1619
Benchmark Electronics
BHE
$2.96B
| $37.3M | ﹤0.01% |
841,602
+21,355
| +3% | +$891K |
|
1620
Apogee Enterprises
APOG
$908M
| $37.1M | ﹤0.01% |
530,226
+7,382
| +1% | +$475K |
|
1621
LiveRamp
RAMP
$2.3B
| $37M | ﹤0.01% |
1,493,522
+15,340
| +1% | +$419K |
|
1622
National Healthcare
NHC
$3.38B
| $36.8M | ﹤0.01% |
292,486
-9,711
| -3% | -$1.22M |
|
1623
BioCryst Pharmaceuticals
BCRX
$2.4B
| $36.8M | ﹤0.01% |
4,837,985
+127,708
| +3% | +$971K |
|
|
HEES
1624
DELISTED
H&E Equipment Services
HEES
| $36.8M | ﹤0.01% |
755,017
+4,226
| +0.6% | +$199K |
|
1625
Crescent Energy
CRGY
$3.82B
| $36.7M | ﹤0.01% |
3,354,700
+1,164,306
| +53% | +$13.3M |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.